Moderator: Alexander Tuchman, MD
156. Forecasting spinal deformity healthcare burden and operative utilization in the United States from 2015 to 2040: An Epidemiological-based Auto-Regressive Integrated Moving Average (ARIMA) computation modeling
Piyush Kalakoti, MD1; Richard P. Menger, MD2; Nathan R. Hendrickson, MD3; Alan Shamrock, MD4; Joshua M. Eisenberg, MD3; Comron Saifi, MD5; Daniel M. Sciubba, MD6; Meic H. Schmidt, MD, MBA7; Andrew J. Pugely, MD1
1University of Iowa, Iowa City, IA, US; 2Shreveport, LA, US; 3University of Iowa, Department of Orthopedics, Iowa City, IA, US; 4University of Iowa Hospitals and Clinics, Iowa City, IA, US; 5William Dyson, Philadelphia, PA, US; 6John Hopkins University/School of Medicine, Baltimore, MD, US; 7New York Medical College, Westchester Medical Center & Health Network, Valhalla, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
157. Economic Analysis of 90-day return to the emergency room and readmission after elective lumbar spine surgery: a single center analysis of 5,444 patients
Marcel R. Wiley, MD1; Leah Y. Carreon, MD, MSc1; Mladen Djurasovic, MD1; Steven D. Glassman, MD1; Yehia H. KHalil, PhD2; Michelle Kannapel; Jeffrey L. Gum, MD1
1Norton Leatherman Spine Center, Louisville, KY, US; 2Norton Healthcare, Louisville, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
158. Determinants of variability in observed costs in spinal surgery episodes within the bundled care payment initiative
Patrick Dermarkarian, MD, MBA1; Sigurd H. Berven, MD2
1University of California San Francisco, San Francisco, CA, US; 2UCSF, Dept of Orthopaedic Surgery, San Francisco, CA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
159. A financial analysis of outpatient spine clinic: an analysis of 36,312 patient appointments and subsequent surgeries at a single major academic institution
Aditya Mazmudar, BA1; Benjamin Hopkins, MD2; Prithvi R. Bomdica, BS1; Alpesh A. Patel, MD, FACS3; Nader S. Dahdaleh, MD1
1Chicago, IL, US; 2Northwestern Memorial, Chicago, IL, US; 3Northwestern Department of Orthopaedics, Chicago, IL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
160. Increasing cost efficiency in adult spinal deformity surgery: identifying predictors of lower total costs
Peter G. Passias, MD1; Avery Brown, BS2; Renaud Lafage, MSc3; Virginie Lafage, PhD3; Christopher P. Ames, MD4; Douglas C. Burton, MD5; Jeffrey L. Gum, MD6; Robert A. Hart, MD7; Richard A. Hostin Jr., MD8; Khaled M. Kebaish, MD9; Brian J. Neuman, MD10; Shay Bess, MD11; Breton Line, BS12; Christopher I. Shaffrey, MD13; Justin S. Smith, MD, PhD14; Frank J. Schwab, MD3; Eric O. Klineberg, MD15; International Spine Study Group16
1NY Spine Institute, NYU Langone Health, New York, NY, US; 2Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 3Hospital for Special Surgery, New York, NY, US; 4University of California, San Francisco, San Francisco, CA, US; 5University of Kansas Medical Center, Kansas City, KS, US; 6Norton Leatherman Spine Center, Louisville, KY, US; 7Swedish Neuroscience Institute, Seattle, WA, US; 8Southwest Scoliosis Institute, Plano, TX, US; 9Johns Hopkins University, Baltimore, MD, US; 10Baltimore, MD, US; 11Denver, CO, US; 12Denver International Spine Center, Denver, CO, US; 13University of Virginia, Charlottesville, VA, US; 14UVA Health System, Charlottesville, VA, US; 15UC, Davis School of Medicine, Sacramento, CA, US; 16Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
161. Effects of Drug Enforcement Agency (DEA) narcotic restrictions on a multi-disciplinary spine practice: analysis of patient discharges from the practice during a ten-year period
Jennifer J. Shivers, PA-C1; Donna D. Ohnmeiss, PhD1; Andrew R. Block, PhD2
1Plano, TX, US; 2Texas Back Institute, Plano, TX, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
162. Opioid usage patterns, patient characteristics, and the role of chiropractic services in a publicly funded inner city healthcare facility
Steven Passmore, DC, PhD1; Christian Manansala, DC2; Quinn Malone, BS3; E A. Toth, DC4; Gerald M. Olin, BS, DC5
1University of Manitoba, Winnipeg, MB, Canada; 2The Wellness Institute – Powered by Seven Oaks General Hospital, Winnipeg, MB, Canada; 3University of Manitoba Faculty of Kinesiology and Recreation Management, Winnipeg, MB, Canada; 4Mount Carmel Clinic, Winnipeg, MB, Canada; 5T.E.A.M. Chiropractic, Winnipeg, MB, Canada
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion